Focusing on the eraser ALKBH5, several experimental systems indicate that m6A demethylation promotes immunosuppressive myeloid states: in colorectal cancer, ALKBH5 upregulated CPT1A and drove M2 polarization, facilitating tumor progression; genetic or pharmacologic interference reduced M2 programs (91). The gene discussed is ALKBH5; the disease is colorectal cancer.